Table 1 Correlation between clinicopathological parameters and (A) CBX 1–4, (B) CBX 5–8.

From: Bioinformatic analysis of the expression and prognostic value of chromobox family proteins in human breast cancer

 

CBX1

CBX2

(A)

Age

 ≤ 51 =  > 51 (P = 0.1740)

 ≤ 51 >  > 51 (P < 0.0001)

ER

 +  <  − (P = 0.0168)

 +  <  − (P < 0.0001)

PR

 +  =  − (P = 0.6980)

 +  <  − (P < 0.0001)

HER-2

 +  >  − (P = 0.0175)

 +  >  − (P < 0.0001)

Nodal status

 +  >  − (P = 0.0167)

 +  >  − (P = 0.0079)

P53 status

Wild type < mutated (P = 0.0007)

Wild type < mutated (P < 0.0001)

TNBC status

TNBC > not TNBC (P = 0.0341)

TNBC > not TNBC (P < 0.0001)

SBR

SBR1 < SBR2 < SBR3 (P < 0.0001)

SBR1 < SBR2 < SBR3 (P < 0.0001)

NPI

NPI1 < NPI2 = NPI3 (P < 0.0001)

NPI1 < NPI2 < NPI3 (P < 0.0001)

 

CBX3

CBX4

Age

 ≤ 51 =  > 51 (P = 0.0843)

 ≤ 51 <  > 51 (P < 0.0001)

ER

 +  <  − (P = 0.0040)

 +  >  − (P < 0.0001)

PR

 +  =  − (P = 0.4357)

 +  >  − (P < 0.0001)

HER-2

 +  =  − (P = 0.1457)

 +  <  − (P = 0.0005)

Nodal status

 +  >  − (P = 0.0003)

 +  >  − (P = 0.0130)

P53 status

Wild type < mutated (P < 0.0001)

Wild type > mutated (P < 0.0001)

TNBC status

TNBC > not TNBC (P = 0.0115)

TNBC < not TNBC (P < 0.0001)

SBR

SBR1 < SBR2 < SBR3 (P < 0.0001)

SBR1 < SBR2 = SBR3 (P = 0.0083)

NPI

NPI1 < NPI2 < NPI3 (P < 0.0001)

NPI1 < NPI2 = NPI3 (P = 0.0005)

 

CBX5

CBX6

(B)

Age

 ≤ 51 =  > 51 (P = 0.4356)

 ≤ 51 =  > 51 (P = 0.9725)

ER

 +  >  − (P < 0.0001)

 +  >  − (P < 0.0001)

PR

 +  >  − (P < 0.0001)

 +  >  − (P = 0.0002)

HER-2

 +  <  − (P < 0.0001)

 +  <  − (P < 0.0001)

Nodal status

 +  =  − (P = 0.3564)

 +  <  − (P < 0.0001)

P53 status

Wild type = mutated (P = 0.8605)

Wild type > mutated (P < 0.0001)

TNBC status

TNBC < not TNBC (P = 0.0005)

TNBC < not TNBC (P = 0.0009)

SBR

SBR1 > SBR2 > SBR3 (P < 0.0001)

SBR1 > SBR2 > SBR3 (P < 0.0001)

NPI

NPI1 > NPI2 > NPI3 (P < 0.0001)

NPI1 > NPI2 > NPI3 (P < 0.0001)

 

CBX7

CBX8

Age

 ≤ 51 <  > 51 (P < 0.0001)

 ≤ 51 =  > 51 (P = 0.4638)

ER

 +  >  − (P < 0.0001)

 +  >  − (P = 0.0083)

PR

 +  >  − (P < 0.0001)

 +  =  − (P = 0.8690)

HER-2

 +  <  − (P < 0.0001)

 +  >  − (P = 0.0144)

Nodal status

 +  <  − (P = 0.0174)

 +  =  − (P = 0.0932)

P53 status

Wild type > mutated (P < 0.0001)

Wild type = mutated (P = 0.7531)

TNBC status

TNBC < not TNBC (P < 0.0001)

TNBC = not TNBC (P = 0.6027)

SBR

SBR1 > SBR2 > SBR3 (P < 0.0001)

SBR1 < SBR2 < SBR3 (P < 0.0001)

NPI

NPI1 > NPI2 > NPI3 (P < 0.0001)

NPI1 < NPI2 < NPI3 (P < 0.0001)

  1. CBXs chromobox family proteins, ER estrogen receptor, PR progesterone receptor, HER-2 human epidermal growth factor receptor 2, P53 a tumor suppressor gene, TNBC triple-negative breast cancer, SBR the Scarff–Bloom–Richardson (SBR) grade, NPI the Nottingham prognostic index.